Life science expertise at scale

Unlock possibility with an AI operating system built for biopharma

Unlock possibility with an AI operating system built for biopharma.

Get in touch

Life science expertise at scale

Unlock possibility with an AI operating system built for biopharma

Get in touch

Multiply your team’s impact

Convoke unifies your internal knowledge, workflows, and external data into a continuously updating workspace. Automate analysis, codify decision logic, and accelerate outputs across drug development and commercialization.

Explore the Platform

Supporting critical decisions across biopharma functions

Explore use cases

Business Development

Competitive Intelligence

Portfolio Strategy

Market Research

Medical Affairs

If you have valuable internal data but face a bottleneck in connecting it to external intelligence at scale, Convoke can bridge that gap quickly. Their ability to adapt to evolving evaluation frameworks, incorporate new data sources on the fly, and deliver ranked, rationale-backed shortlists means you spend far more time acting on the best opportunities—and far less time sifting through noise.”

—

Chris Towne,

VP Preclinical Research and Gene Therapy

If you have valuable internal data but face a bottleneck in connecting it to external intelligence at scale, Convoke can bridge that gap quickly. Their ability to adapt to evolving evaluation frameworks, incorporate new data sources on the fly, and deliver ranked, rationale-backed shortlists means you spend far more time acting on the best opportunities—and far less time sifting through noise.”

—

Chris Towne,

VP Preclinical Research and Gene Therapy

If you have valuable internal data but face a bottleneck in connecting it to external intelligence at scale, Convoke can bridge that gap quickly. Their ability to adapt to evolving evaluation frameworks, incorporate new data sources on the fly, and deliver ranked, rationale-backed shortlists means you spend far more time acting on the best opportunities—and far less time sifting through noise.”

Chris Towne,

VP Preclinical Research and Gene Therapy